TN2013000034A1 - Heterocyclic compound and use thereof - Google Patents

Heterocyclic compound and use thereof

Info

Publication number
TN2013000034A1
TN2013000034A1 TNP2013000034A TN2013000034A TN2013000034A1 TN 2013000034 A1 TN2013000034 A1 TN 2013000034A1 TN P2013000034 A TNP2013000034 A TN P2013000034A TN 2013000034 A TN2013000034 A TN 2013000034A TN 2013000034 A1 TN2013000034 A1 TN 2013000034A1
Authority
TN
Tunisia
Prior art keywords
heterocyclic compound
compound
ampa
adhd
schizophrenia
Prior art date
Application number
TNP2013000034A
Other languages
English (en)
Inventor
Masakuni Kori
Toshihiro Imaeda
Shinji Nakamura
Masashi Toyofuku
Eiji Honda
Yasutomi Asano
Osamu Ujikawa
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2011/068497 external-priority patent/WO2012020848A1/fr
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of TN2013000034A1 publication Critical patent/TN2013000034A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TNP2013000034A 2011-08-09 2013-01-29 Heterocyclic compound and use thereof TN2013000034A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2011/068497 WO2012020848A1 (fr) 2010-08-10 2011-08-09 Composé hétérocyclique et son utilisation

Publications (1)

Publication Number Publication Date
TN2013000034A1 true TN2013000034A1 (en) 2014-06-25

Family

ID=54360746

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000034A TN2013000034A1 (en) 2011-08-09 2013-01-29 Heterocyclic compound and use thereof

Country Status (1)

Country Link
TN (1) TN2013000034A1 (fr)

Similar Documents

Publication Publication Date Title
MX349470B (es) Compuesto heterocíclico y su uso.
WO2012137982A3 (fr) Dérivé de sulfonamide et son utilisation
MX2015002511A (es) Compuestos de dihidropirimidina y su aplicacion en productos farmaceuticos.
MX2014006026A (es) Derivados de aminopirimidina como moduladores de proteina cinasa 2 rica en unidades repetitivas de leucina (lrrk2).
MX348606B (es) Derivados de aminopirimidina como moduladores de proteina cinasa 2 de repeticion rica en leucina (lrrk2).
TN2014000122A1 (en) 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
PH12015500376B1 (en) Novel bicyclic pyridinones
MX347241B (es) Derivados de aminopirimidina para usarse como moduladores de la actividad de cinasa.
PH12014501417A1 (en) Dihydro-benzo-oxazine and dihydro-pyrido-oxazine derivatives
BR112012029647A2 (pt) novos derivados de pirimidinas
EA201200471A1 (ru) Простые эфирные производные бициклических гетероарилов
GB201209587D0 (en) Therapeutic compounds
MX2013008699A (es) Compuestos para reducir la produccion de beta-amiloide.
GEP201706655B (en) Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
PH12015501146A1 (en) Hydantoin derivative
MX350430B (es) Proceso para preparar compuestos acido 4-amino-5-bifenil-4-il-2-hi droximetil-2-metil-pentanoico.
TN2013000034A1 (en) Heterocyclic compound and use thereof
NZ724424A (en) Pyrimidine derivatives for the treatment of bacterial diseases
CA2863110A1 (fr) Derives de 1,2-pyridazine, 1,6-pyridazine ou pyrimidine-benzamide comme modulateurs de gpbar1
EA201390619A1 (ru) 3-замещенные 6-(пиридинилметокси)пирролопиридиновые соединения
GB2527958A (en) Pregnane-oximino-aminoalkylethers and process for preparation thereof, useful as antidiabetic and antidyslipidemic agents
UA103803C2 (en) Use of 1-methoxycarbonylmethyl-7-bromo-5-phenyl-3-arylamino-1,2-dihydro-3h-1,4-benzodiazepine-ones as analgetic agents